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Chronic infl ammatory joint and intestinal diseases are often coexpressed in individual patients, indicating common underlying pathogenic mechanisms. Epidemiological studies revealed that a substantial group of patients suff ering from spondyloarthritis shows asymptomatic gut infl ammation, and some of them (7%) eventually develop infl ammatory bowel disease (IBD), particularly Crohn ' s disease (CD) ( 1, 2 ) . Conversely, spondyloarthritis is not uncommonly associated with IBD ( 3 ) . The coexistence of these diseases is usually classifi ed in the group of spondyloarthropathies (SpAs) and is defi ned as interrelated and overlapping chronic infl ammatory diseases that mainly include ankylosing spondylitis, reactive and psoriatic arthritis, and CD ( 4 ) .
Spondyloarthritis, rheumatoid arthritis, and CD are diseases showing major clinical responses to anti-TNF treatment ( 5, 6 ). An important fi nding validating the role of TNF in specifi cally driving infl ammatory arthritis in vivo was provided by the generation of transgenic mice overexpressing human TNF ( Tg197 mice) and developing chronic infl ammatory polyarthritis, which was reversible by anti -human TNF antibody administration ( 7 ) . More recently, it was recognized that Tg197 mice also develop spondyloarthritis ( 8 ) . Importantly, a previously established TNF-overexpressing mouse model ( Tnf ⌬ ARE mice) characterized by the development of both chronic infl ammatory polyarthritis and Crohn ' s-like IBD ( 9 ) is shown in this report to also develop extraintestinal features of spondyloarthritis such as sacroiliitis and enthesitis. These results establish Tnf ⌬ ARE mice as a new model for SpAs uniquely associated with CD (similarly to human SpAs), off ering an appropriate system in which further mechanistic studies, including a potential common basis of TNF function in these pathologies, can be explored.
Mechanistic hypotheses addressing the coincidence of gut -joint axis diseases in humans favor an aetiopathogenic role for common molecular determinants on eff ector lymphocytes, Tumor necrosis factor (TNF) is key to the pathogenesis of various arthritic diseases and infl ammatory bowel disease (IBD). Anti-TNF therapies have proved successful in the clinical treatment of these diseases, but a mechanistic understanding of TNF function is still lacking. We have investigated early cellular mechanisms of TNF function in these diseases using an established TNF transgenic model, which develops a spondyloarthritis-like disease characterized by peripheral joint arthritis, sacroiliitis, enthesitis, and Crohn ' s-like IBD. Bone marrow grafting experiments demonstrated that development of arthritis requires TNF receptor I (TNFRI) expression in the radiation-resistant compartment, which is also known to be a suffi cient target of TNF in the development of Crohn ' s-like IBD in the same model. Early activation of synovial fi broblasts and intestinal myofi broblasts could also be demonstrated by perturbed expression of matrix metalloproteases and their inhibitors. Notably, selective Cre/loxP-mediated TNFRI expression in mesenchymal cells resulted in a fully arthritic -spondyloarthritic and intestinal phenotype, indicating that mesenchymal cells are primary and suffi cient targets of TNF in these pathologies. Our results offer a novel mechanistic perspective for TNF function in gut and joint pathologies and indicate early common cellular pathways that may also explain the often observed synovial -gut axis in human disease.
poietic or radiation-resistant tissue stromal cells. Using this system, we have previously reported the capacity of BMderived cells from the Tnf ⌬ ARE mice to induce IBD and, more importantly, that radiation-resistant, tissue stroma -residing cells are suffi cient TNF targets for the induction of IBD ( 12 ) . We have now extended these previous fi ndings by demonstrating that at 12 wk after transplantation, lethally irradiated WT mice transplanted with Tnf ⌬ ARE/+ BM cells also develop arthritis ( Table I ; and Fig. S1 A, available at http://www.jem.org/cgi/content/full/jem.20070906/DC1), indicating that a source of pathogenic TNF production in this model resides within the hematopoietic compartment. Transfer of Tnf ⌬ ARE/ ⌬ ARE TnfRI Ϫ / Ϫ BM into WT irradiated recipients resulted in overt arthritis, similar to the Tnf ⌬ ARE/+ -reconstituted WT mice, as indicated by histo pathological analysis of joints performed 12 wk after engraftment ( Table I and Fig. S1 B) , suggesting that radiation-resistant, stroma -residing cells are suffi cient TNF targets for the induction of arthritis. Reciprocal engraftment of Tnf ⌬ ARE/+ BM into TnfRI Ϫ / Ϫ recipients did not result in any arthritic manifestation 12 wk after transplantation ( Table I and Fig.  S1 C), indicating that radiation-resistant, tissue stromaresiding cells are also required TNF targets for the induction of arthritis. Similar results were obtained using the huTNF transgenic Tg197 model of arthritis (unpublished data). Collectively, these results demonstrate that in TNFmediated arthritis, TNFRI expression on radiation-resistant cells is a necessary and suffi cient condition for the development of disease.
Early activation of mesenchymal cells in modeled arthritis and Crohn ' s-like IBD In infl amed tissues, mesenchymal cells become activated and act as both recruiters of lymphocytes, by the increased expression of adhesion molecules ( 15, 16 ) , and as eff ectors of tissue destruction, through the production of several matrix degrading enzymes such as matrix metalloproteinases (MMPs) ( 17, 18 ) . Importantly, TNFRI-mediated mesenchymal MMP secretion in human fetal small intestine explant cultures has been previously associated with intestinal injury ( 19 ) . To examine whether mesenchymal cells of Tnf ⌬ ARE mice are activated before the onset of disease, we isolated synovial fi broblasts (SFs) of ankle joints and intestinal myofi broblasts (IMFs) from WT and Tnf ⌬ ARE/+ mice before the appearance of the infl ammatory infi ltrate (at 4 wk of age) ( 9, 12 ) . Increased proteolytic activity against gelatin caused by MMP9 expression was detected in SF and IMF cell extracts in contrast to MMP2 activity, which remained unaltered ( Fig. 2 A ) . Additionally, semiquantitative RT-PCR revealed the up-regulation of MMP3 and the strong down-regulation of tissue inhibitor of MMPs 1 (TIMP1) messenger RNA, leading to severely misbalanced ratios of MMP3 versus TIMP1 expression in both SF and IMF cells of Tnf ⌬ ARE/+ compared with WT mice ( Fig. 2 B ) . Furthermore, using immunofl uorescent staining of ex vivoderived SFs and IMFs, we detected elevated protein expression of MMP3 and MMP9 in Tnf ⌬ ARE cultures (Fig. S2 , which render them capable of homing equally effi ciently to the intestinal mucosa and joints ( 10 ) . An experimental model in support of this hypothesis, the HLA-B27 transgenic rat, a spontaneous model for SpAs, develops colitis, gastritis, and arthritis ( 11 ) . Although adaptive immune responses and, more specifi cally, CD8 + eff ector function are required for the development of Crohn ' s-like IBD in the Tnf ⌬ ARE model ( 12 ) , arthritis develops independently of the adaptive immune compartment ( 9 ) , indicating that T cell responses may not be commonly required in the pathogenesis of these two diseases. Therefore, alternative mechanisms are likely to be responsive for TNF-mediated pathology in gut -joint diseases. Current hypotheses suggest that TNF delivers innate activation and proinfl ammatory signals through its action on various cell types, including myeloid/monocytic, lymphocytic, endothelial, mesenchymal, or epithelial cell types ( 5, 13 ) . Using TNF-driven disease models, we demonstrate for the fi rst time that mesenchymal cells, such as the fi broblasts/ myofi broblasts of the joint and the intestine, are primary responder cells suffi cient for full pathogenic TNF/TNFRI signaling in arthritis, sacroiliitis, and Crohn ' s-like IBD. Our fi ndings provide novel mechanistic insights into the cellular and molecular events underlying TNF function in joint -gut axis diseases and establish an early dominant role for mesenchymal cell responses in their pathogenesis.
RESULTS AND DISCUSSION
Tnf ⌬ ARE mice as a model for SpAs Tnf ⌬ ARE/+ mutant mice have been described previously ( 9, 12 ) to develop chronic polyarthritis starting at weeks 5 -6 and Crohn ' s-like IBD starting at week 6. Prompted by the coincidence of both joint and intestinal disease in these mice, we have examined whether additional features of spondyloarthritic disease are developing in this model. Histological analysis of sacroiliac joints from Tnf ⌬ ARE/+ mice revealed bilateral infl ammation of the sacroiliac joints, a prominent feature of ankylosing spondylitis. Invasion of infl ammatory tissue was detected in the subchondral bone and iliac BM of Tnf ⌬ ARE/+ mice ( Fig. 1 ) . Initial signs of enthesitis were evident by week 4 (not depicted). No gender bias was apparent. These data establish Tnf ⌬ ARE mutant mice as a disease model resembling human SpAs. Interestingly, the Tnf ⌬ ARE model is characterized by the combined presence of arthritis -spondyloarthritis with a CD-like pathology localized primarily in the small intestine, as typically occurs in patients suff ering from SpAs ( 2 ).
TNFRI expression on radiation-resistant, tissue stroma -residing cells is necessary and suffi cient for the induction of arthritis
The dominant role of TNFRI in mediating TNF pathogenic signals in modeled arthritis and IBD has been previously established ( 7, 9 ) . To gain further insight into the cellular specifi city of TNFRI-mediated signaling, we used BM engraftment experiments into lethally irradiated recipients, using TNFRI-defi cient mice ( 14 ) as either recipients or donors, to restrict TNFRI expression in either hemato-
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collagen VI (ColVI) promoter cassette ( Fig. S3 A, available at http://www.jem.org/cgi/content/full/jem.20070906/DC1), which is known to drive gene expression in mesenchymal cell types ( 20 ) . The specifi city of Cre-mediated recombi nation in the ColVI-Cre mice was assessed using the ROSA26 and Z/ EG reporter mouse strains ( 21, 22 ) . X-gal staining in various tissues of ColVI-Cre ROSA26 fl x/+ mice indicated Cre-mediated recombination in joint SFs, articular chondrocytes and myocytes, skin keratinocytes and dermal fi broblasts, the muscle layer around arteries of the heart (not depicted), and underneath the epithelial layer of the gut (Fig. S3 , B -E). Cre activity was not detected in hematopoietic tissues (spleen and thymus; not depicted). Effi ciency of Cre-mediated recombination in ex vivo -cultured SFs measured by fl ow cytometric analysis using fl uorodeoxyglucose staining was > 80% (Fig. S3 F) . The localization of X-gal -positive cells neighboring the epithelium of ColVI-Cre ROSA26 fl x/+ reporter mice indicated Cre recombinase expression in the subepithelial myofi broblast cell layer (Fig. S3, D and E) . Indeed, in ColVI-Cre Z/EG mice ( 22 ), GFP-expressing cells stained positive for ␣ SMA (Fig. S3 , J -L) but negative for the CD31 endothelial cell marker (Fig. S3, G -I) , indicating Cre-mediated recombination in subepithelial myofi broblasts.
To obtain mesenchymal cell -specifi c expression of TNFRI, we used previously generated mutant mice carrying a conditional gain-of-function allele for this receptor (TnfRI fl xneo mice). In these mice, TNFRI expression is inhibited by the presence of a fl oxed neomycin cassette but is restored upon Cre-mediated neo excision ( 23 ) . The specifi city of recombination for the fl oxed neo TNFRI allele was examined in A and B, respectively, available at http://www.jem.org/cgi/ content/full/jem.20070906/DC1). Interestingly, we detected ␣ -smooth muscle actin ( ␣ SMA) expression by SFs as well as IMFs (Fig. S2 C) , suggesting common phenotypic features between these two cell types. These results indicate that mesenchymal/myofi broblast-like cells of Tnf ⌬ ARE mice may represent the local primary targets of TNF in the induction of joint and gut pathology. Misbalanced production of MMPs and TIMPs by SFs and IMFs confi rms early proinfl ammatory triggering that could potentially promote primary matrix degradation in the respective tissues.
TNFRI-expressing mesenchymal cells are suffi cient TNF targets for the development of SpA-related pathologies To investigate the specifi c role of mesenchymal cells in the Tnf ⌬ ARE and Tg197 pathologies, we generated transgenic mice expressing Cre recombinase under the control of a whereas Tnf ⌬ ARE/+ TnfRI fl xneo/+ littermates developed intestinal pathology ( Table II ) . Furthermore, the spondylo arthritic characteristic of bilateral sacroiliitis observed in the Tnf ⌬ ARE model was also evident in the ColVI-Cre Tnf ⌬ ARE/+ TnfRI fl xneo/fl xneo mice examined at 40 wk of age but not in Tnf ⌬ ARE/+ TnfRI fl xneo/fl xneo control mice (four mice per group; Fig. 3 , E and F, respectively ). Notably, introduction of the ColVI-Cre transgene in the Tg197 TnfRI fl xneo/fl xneo background also resulted in the development of progressive infl ammatory arthritis starting at 5 -6 wk of age and with 100% incidence (10 out of 10 mice), similar to the timing and course of disease seen in Tg197 mice ( Fig. 3 G ) . Littermate control Tg197 TnfRI fl xneo/fl xneo mice remained healthy even at 50 wk of age (15 out of 15 mice; Fig. 3 H ) , further confi rming the suffi ciency of TNFRI signaling in mesenchymal cells for the development of TNF-driven arthritis. Southern blot analysis of tissue DNA from ColVI-Cre Tg197 TnfRI fl xneo/fl xneo mice confi rmed the recombination of the TNFRI fl xneo allele in joints, skeletal muscle, skin, gut, and heart ( Fig. 3 I ) . These fi ndings demonstrate that mesenchymal cells are common primary targets for TNF in the development of infl ammatory polyarthritis, Crohn ' s-like IBD, and anklylosing spondylitis, and that selective expression of TNFRI on these cells is suffi cient to orchestrate the complete development of such SpA-related pathologies. ( Fig. 3 C ) . None of the Tnf ⌬ ARE/+ TnfRI fl xneo/fl xneo littermates exhibited signs of disease ( Fig. 3 D ) , 
early marker of SF and intestinal subepithelial fi broblast activation by TNF. Increased levels of MMP3 and other MMPs have been reported in CD ( 24 ) and arthritic patients ( 25 ) . Sustained perturbations on MMP expression are now strongly
Collectively, the data in this study demonstrate that mesenchymal cell targeting by TNF represents a common pathogenic mechanism in chronic infl ammatory joint and intestinal diseases. Deregulated MMP expression was detected as an The ColVI promoter cassette used for the generation of ColVI-Cre mice was provided by G. Bressan (University of Milano, Milano, Italy). All mice were bred and maintained on C57BL/6J and on mixed C57BL/6J × 129S6 or C57BL/6 × CBA genetic backgrounds in the animal facilities of the BSRC " Alexander Fleming " under specifi c pathogen-free conditions. All mice were used in accordance with the guidance of the Institutional Animal Care and Use Committee of BSRC " Alexander Fleming. " BM transplantation. BM transplantation experiments were performed as previously described ( 12 ) .
Cell culture. SF cultures were established by enzymatic treatment as previously described ( 1 ) . IMF cultures were established by enzymatic treatment of terminal ilea (5 cm). In brief, the intestinal pieces were fl ushed extensively with HBSS (Sigma-Aldrich)/2% FBS (Biochrome), and cut longitudinally. The epithelial layer was removed by incubation in DMEM/10% FBS-containing collagenase XI (300 U/ml)/dispase (0.1 mg/ml; Sigma-Aldrich) for 10 min at 30 ° C. The digested tissues were washed with HBSS/2% FBS and subjected to a second incubation with collagenase/dispase for 20 min at 30 ° C. The mucosal samples were then washed and cultured at 37 ° C in a humidifi ed CO 2 incubator in DMEM (Invitrogen) supplemented with 10% FBS, 1% nonessential amino acids, 100 U/ml penicillin, 100 g/ml streptomycin (Invitrogen), and 1 g/ml amphotericin B (Sigma-Aldrich). Cells were used after three passages. The purity of myofi broblast cultures was determined by fl ow cytometric detection of CD90 (BD Biosciences) and ␣ SMA (Sigma-Aldrich) expression. The generation of BM-derived macrophages was performed as previously described ( 9 ) .
Gelatin zymography and Western blotting. In brief, synchronized cells were grown in confl uence on 10-cm plates in the presence or absence of 20 ng/ml of mouse TNF. Cell extracts (in 50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 2 g/ml leupeptin, 2 g/ml aprotinin, 1mM PMSF) were collected at the time points indicated in the fi gures. The samples were sonicated and stored at Ϫ 70 ° C until use. 20 μ g of total protein per sample was analyzed on 8% SDS-PAGE containing 1 mg/ml of gelatin under nonreduced conditions, at 4 ° C, and at a constant voltage (100 V). The gel was rinsed for 60 min in 2.5% Triton X-100 and incubated in MMP activation buff er (50 mM Tris-HCl [pH 7.5], 5 mM CaCl 2 , 0.02% NaN 3 , 1 M ZnCl 2 ) for 36 h at 37 ° C with constant shaking. Gels were stained for 30 min with 0.5% Coomassie blue R250 and destained in 40% methanol/10% acetic acid. The gels were stored either dried or in water/20% glycerol. The specifi city of reaction was tested with the use of specifi c inhibitors that were added to the activation buff er (10 mM EDTA and 0.1 mM phenantroline). For detection of actin, 20 mg of total protein per sample was analyzed on 8% SDS-PAGE, electrotransfered in nitrocellulose membrane, and detected with Western blot analysis using polyclonal antibodies against actin (Santa Cruz Biotechnology, Inc.).
RNA isolation and RT. RNA was isolated with TRI zol (Invitrogen). RT to complementary DNA was performed with 12 μ g RNA by MMLV-RT (Promega) at a fi nal volume of 20 l, according to manufacturer ' s instructions. The volume of the reaction was increased to 50 μ l and the dilutions used in reactions were always performed in accordance with the housekeeping gene content. The sequences of the primers are as follows: MMP3 sense, 5 Ј -CCACAGACTT-GTCCCGTTTCC-3 Ј ; MMP3 antisense, 5 Ј -GAGTCCTGAGAGATTT-GCGCC-3 Ј ; TIMP1 sense, 5 Ј -ACAAGTCCCAGAACCGCAGTA-3 Ј ; TIMP1 antisense, 5 Ј -GGACCTGATCCGTCCACAAAC-3 Ј ; ␤ 2 microglobulin ( ␤ 2 M) sense, 5 Ј -TTCTGGTGCTTGTCTCACTGA-3 Ј ; and ␤ 2 M antisense, 5 Ј -CAGTATGTTCGGCTTCCCATTC-3 Ј . The annealing temperature for all primers was 53 ° C for 30 cycles. Product sizes were as follows: MMP3, 237 bp; TIMP1, 234 bp; and ␤ 2 M, 104 bp.
Online supplemental material. Fig. S1 shows the histopathological manifestations of BM chimeras. Fig. S2 shows the immunohistochemical detection of MMPs in mesenchymal cells of Tnf ⌬ ARE mice before disease onset. implicated in various processes central to infl ammation and immunity, such as cytokine and chemokine production, leukocyte recruitment, and tissue repair ( 26 ) . It is thus possible that, in susceptible hosts, dysfunctional responses to tissue injury, infections, or other environmental stimuli may lead to sustained TNF/TNFRI-dependent activation of mesenchymal cells. Failure to regulate these proinfl ammatory and tissue-repair activities may be responsible for driving the transition of acute-to-chronic tissue infl ammation and fi brosis ( 15 ) . SFs do play a critical role in these processes, as they have been suggested to be capable of propagating both infl ammation and joint destruction in rheumatoid arthritis ( 27, 28 ) . An equally important role may be played by the intestinal subepithelial myofi broblast, which is also considered important in maintaining tissue architecture, regulating infl ammation, and repair in the gut ( 29 ) . Intestinal infl ammation has also been prominently linked to epithelial barrier dysfunction ( 13 ) . It was recently demonstrated that NF-B-defi ciency sensitizes epithelial cells to TNFRI-dependent apoptosis, linking innate immunity to intestinal infl ammation ( 30 ) . It will also be interesting to investigate whether TNFRI-mediated signaling on IMFs may contribute to epithelial barrier dysfunction in CD.
The identifi cation of mesenchymal cells as a cellular subset linking joint and intestinal pathologies provides an alternative cellular basis to understand the common occurrences of these pathologies in humans, as well as the remarkable response of a signifi cant number of patients to anti-TNF therapies ( 6 ) . Mesenchymal cell replacement by stem cell or BM transplantation may off er future therapeutic approaches for the resolution of chronic infl ammatory processes. The identifi cation of TNF-responsive mesenchymal cells as dominant contributors to joint and gut infl ammatory diseases suggests that attenuation of the TNFRI pathway in these cells or their precursors may hold promise for more rational and eff ective therapeutic interventions.
MATERIALS AND METHODS
Mice. The generation of Tg197 ( 7 ), Tnf ⌬ ARE ( 9 ) , and mutant mice carrying a conditional gain-of-function allele for TnfRI ( TnfRI fl xneo mice) have been previously described ( 23 ) . TnfRI Ϫ / Ϫ ( 14 ) and Z/EG ( 22 ) mice were purchased from the Jackson Laboratory. 
